ConductScience.org, home

Trial · NCT05520944

Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis

NCT05520944, Unknown, Dr. Ferrer BioPharma

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis. Trials, record NCT05520944. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05520944

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis
NCT number
NCT05520944
Status
Unknown
Enrollment
1,000 participants, estimated
Lead sponsor
Dr. Ferrer BioPharma
Conditions
COVID-19, COVID-19 Pandemic, COVID-19 Respiratory Infection, SARS CoV 2 Infection, SARS-CoV-2 Acute Respiratory Disease
Interventions
ClorNovir® (Chlorpheniramine) 0.4% Nasal Spray
First posted
2022-08-30
Last updated
2022-08-30

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTime to Clinical RecoveryBaseline through Day 10-End of TreatmentDefined as the change from baseline to end of treatment in COVID-19 symptoms on a 10-item ordinal scale\* ("A minimal common outcome measure set for COVID-19 clinical research," 2020).
PrimaryIncidence of significant COVID-19-related clinical eventsBaseline through Day 10-End of TreatmentSuch as anosmia, dysgeusia, cough, and nasal congestion.
PrimaryIncidence and severity of serious adverse events (SAEs)Baseline through Day 10-End of Treatment
PrimaryIncidence and severity of adverse events (AEs) of interestBaseline through Day 10-End of TreatmentSuch as irritation in the nasal fossa, Headache, Epistaxis, modification or discontinuation
Primarytreatment period in the incidence of hospitalizationsBaseline through Day 10-End of Treatment

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
1100130BACKGROUNDPubMed
32539990BACKGROUNDPubMed
33803811BACKGROUNDPubMed
35652393BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05520944

GET https://conductscience.org/api/trials/v1/NCT05520944/registered